magnolol has been researched along with Cerebral Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HY; Chen, TY; Hung, YC; Lee, EJ; Lee, WT; Lin, MH; Tai, SH; Wu, TS | 1 |
1 other study(ies) available for magnolol and Cerebral Infarction
Article | Year |
---|---|
Magnolol reduces glutamate-induced neuronal excitotoxicity and protects against permanent focal cerebral ischemia up to 4 hours.
Topics: Animals; Biphenyl Compounds; Brain; Calcium; Cells, Cultured; Cerebral Infarction; Dose-Response Relationship, Drug; Glutamic Acid; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Lignans; Male; Neurons; Neuroprotective Agents; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |